ArticleOncotarget2018
Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patients.
Kristian Taipale et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it